Tissue Kallikrein Preventing the Restenosis After Stenting of Symptomatic MCA Atherosclerotic Stenosis
Status:
Unknown status
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The study aims to determine whether tissue kallikrein (TK) is efficacy for preventing the
long-term in-stent restenosis (ISR) after stenting of symptomatic atherosclerotic stenosis of
the middle cerebral artery (MCA) M1 segment